EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Changes in breast cancer risk associated with benign breast disease from 1967 to 2013

Amy C Degnim iD, Karthik Ghosh iD, Robert A Vierkant iD, Stacey J Winham iD, Tanya L Hoskin iD, Jodi M Carter iD, Bryan M McCauley iD, Matt R Jensen, Teresa Allers, Marlene Frost, Denice L Gehling, Jessica L Fischer und 8 weitere

JNCI Cancer Spectrum · 03.01.2025 · 9 (1)

DOI: 10.1093/jncics/pkae128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 30.12.2024. Verfasst von Amy C Degnim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast and Melanoma Surgical Oncology, Mayo Clinic, Rochester, MN 55905, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Diseases, Breast. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Andersen Foundation, NIH HHS, Department of Defense Center of Excellence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Benign breast disease (BBD) increases breast cancer (BC) risk progressively for women diagnosed with nonproliferative change, proliferative disease without atypia (PDWA), and atypical hyperplasia (AH). Leveraging data from 18 704 women in the Mayo BBD Cohort (1967-2013), we evaluated temporal trends in BBD diagnoses and how they have influenced associated BC risk over 4 decades.

Methods

BC risk trends associated with BBD were evaluated using standardized incidence ratios (SIRs) and age–period–cohort modeling across 4 eras—premammogram (1967-1981), precore needle biopsy (CNB) (1982-1992), transition to CNB (1993-2001), and CNB era (2002-2013).

Results

With a median follow-up of 15.8 years, 9.9% of women were diagnosed with BC (invasive and/or DCIS). From the premammogram era to the CNB era, we observed a significant increase in BC risk, rising from an SIR of 1.61 to 1.99. The proportion of proliferative BBD diagnoses (PDWA or AH) increased markedly over time (28.1%-49.7%), as did the proportion of DCIS events (11%-28%; χ2 P < .001). Within specific BBD categories, the risk of invasive BC increased modestly.

Conclusions

Absolute risk of BC within BBD categories remained stable, but the relative risk of BC after BBD increased over time due to notable increases in higher risk BBD lesions, specifically PDWA and AH. These findings illustrate how evolving screening practices have changed the risk profile of BBD and should inform management strategies for patients with BBD in modern clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBreast DiseasesBreastHumansFemaleMiddle AgedAdultIncidenceAgedHyperplasiaRisk FactorsMammographyCarcinoma, Intraductal, NoninfiltratingCohort StudiesFollow-Up Studies

Autor:innen und Institutionen

  • Division of Breast and Melanoma Surgical Oncology, Mayo Clinic, Rochester, MN 55905, United States.
  • General Internal Medicine, Mayo Clinic, Rochester, MN 55905, United States.
  • Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL 32224, United States.
  • Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, United States.
  • Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States.
  • Surgery Clinical Research, Mayo Clinic, Rochester, MN 55905, United States.

ORCID-Profile: Amy C Degnim, Karthik Ghosh, Robert A Vierkant, Stacey J Winham, Tanya L Hoskin, Jodi M Carter, Bryan M McCauley, Laura M Pacheco-Spann, Philip S Rosenberg, Celine M Vachon, Derek C Radisky, Mark E Sherman

Förderung

  • Andersen Foundation
  • NIH HHS
  • Department of Defense Center of Excellence
  • NCI NIH HHS
  • Susan G. Komen Breast Cancer Foundation
  • Breast Cancer Research Foundation
  • National Institutes of Health

Zitieren

APA

Degnim, A. C., Ghosh, K., Vierkant, R. A., Winham, S. J., Hoskin, T. L., Carter, J. M., McCauley, B. M., Jensen, M. R., Allers, T., Frost, M., Gehling, D. L., Fischer, J. L., Seymour, L. R., Pacheco-Spann, L. M., Rosenberg, P. S., Denison, L. A., Vachon, C. M., Hartmann, L. C., Radisky, D. C., & Sherman, M. E. (2025). Changes in breast cancer risk associated with benign breast disease from 1967 to 2013. JNCI Cancer Spectrum, 9(1). https://doi.org/10.1093/jncics/pkae128

Vancouver

Degnim AC, Ghosh K, Vierkant RA, Winham SJ, Hoskin TL, Carter JM, et al. Changes in breast cancer risk associated with benign breast disease from 1967 to 2013. JNCI Cancer Spectrum. 2025;9(1). doi:10.1093/jncics/pkae128

BibTeX
@article{Degnim2025,
  author = {Degnim, Amy C and Ghosh, Karthik and Vierkant, Robert A and Winham, Stacey J and Hoskin, Tanya L and Carter, Jodi M and McCauley, Bryan M and Jensen, Matt R and Allers, Teresa and Frost, Marlene and Gehling, Denice L and Fischer, Jessica L and Seymour, Lisa R and Pacheco-Spann, Laura M and Rosenberg, Philip S and Denison, Lori A and Vachon, Celine M and Hartmann, Lynn C and Radisky, Derek C and Sherman, Mark E},
  title = {Changes in breast cancer risk associated with benign breast disease from 1967 to 2013},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  volume = {9},
  number = {1},
  doi = {10.1093/jncics/pkae128}
}
Kostenlos starten →